
What is CAR T-cell therapy?
Loading player...
New kid on the block.
In this episode, Dr Lucille Sarah Singh details how CAR T-cell therapy works and how it will fit into the South African healthcare system.
This episode is brought to you by Accord Healthcare in the interest of education, awareness, and support. The content and opinions expressed are entirely those of the healthcare professional and not influenced by Accord Healthcare in any way.
Accord Healthcare is one of the fastest-growing generic pharmaceutical companies with a direct presence in all major markets, Americas, the EU, Asia, and Africa. Accord Healthcare is an Oncology leader with a 30% global volume share of major chemotherapy molecules. The cornerstone of Accord’s offering to the South African market is exceptional quality, affordability and service to healthcare professionals and their patients.
Dr Lucille Sarah Singh is a physician and clinical haematologist in private practice at Albert’s Cellular Therapy (ACT) based at Netcare Pretoria East Hospital. She is an active member of the South African Society of Haematology (SASH) and the South African Stem Cell Transplant Society (SASCeTS) and serves regularly on the clinical review panel of the South African Oncology Consortium (SAOC).
In this episode, Dr Lucille Sarah Singh details how CAR T-cell therapy works and how it will fit into the South African healthcare system.
This episode is brought to you by Accord Healthcare in the interest of education, awareness, and support. The content and opinions expressed are entirely those of the healthcare professional and not influenced by Accord Healthcare in any way.
Accord Healthcare is one of the fastest-growing generic pharmaceutical companies with a direct presence in all major markets, Americas, the EU, Asia, and Africa. Accord Healthcare is an Oncology leader with a 30% global volume share of major chemotherapy molecules. The cornerstone of Accord’s offering to the South African market is exceptional quality, affordability and service to healthcare professionals and their patients.
Dr Lucille Sarah Singh is a physician and clinical haematologist in private practice at Albert’s Cellular Therapy (ACT) based at Netcare Pretoria East Hospital. She is an active member of the South African Society of Haematology (SASH) and the South African Stem Cell Transplant Society (SASCeTS) and serves regularly on the clinical review panel of the South African Oncology Consortium (SAOC).